Drug Type Small molecule drug |
Synonyms BMT-145027 |
Target |
Action positive allosteric modulator |
Mechanism mGluR5 positive allosteric modulator(Metabotropic glutamate receptor 5 positive allosteric modulator) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H14ClF3N4 |
InChIKeyUXLUNMKSQUMWLH-UHFFFAOYSA-N |
CAS Registry2018282-44-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cognition Disorders | Preclinical | United States | 04 Oct 2016 |





